Urology Medical News about Prostatic hyperplasia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prostate growth inhibition by subtype-selective alpha1-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia
The Prostate, 06/22/09

Kojima Y et al. - Alpha1d-AR may play an important role in the regulation of cellular proliferation in the prostate, and alpha1d-AR blockage by naftopidil may not only improve lower urinary tract symptoms but also inhibit prostate growth in BPH patients.

<< Previous
Metastasis of genitourinary tumors to the head and neck region

Next >>
Does Open Stone Surgery Still Play a Role in the Treatment of...

Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia
The Prostate, 11/18/09 Relevance Score: 68%

Resistive Index: A Newly Identified Predictor of Outcome of Transurethral Prostatectomy in Patients With Benign Prostatic Hyperplasia
Urology, 11/12/09 Relevance Score: 68%

Differences in Initial Benign Prostatic Hyperplasia Management Between Primary Care Physicians and Urologists
The Journal of Urology, 11/02/09 Relevance Score: 67%

Stone Formation in Prostatic Urethra After Potassium-Titanyl-Phosphate Laser Ablation of the Prostate for Benign Prostatic Hyperplasia
Journal of Endourology, 10/13/09 Relevance Score: 67%

Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world
Indian Journal of Urology, 10/08/09 Relevance Score: 66%